Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines …

CA MACKINTOSH, DJ FEITH, LM SHANTZ… - Biochemical …, 2000 - portlandpress.com
Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the
heart, driven from the cardiac α-myosin heavy chain promoter. The use of engineered …

Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines …

CA Mackintosh, DJ Feith, LM Shantz… - Biochemical …, 2000 - ncbi.nlm.nih.gov
Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the
heart, driven from the cardiac alpha-myosin heavy chain promoter. The use of engineered …

Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines …

CA Mackintosh, DJ Feith, LM Shantz… - The Biochemical …, 2000 - europepmc.org
Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the
heart, driven from the cardiac alpha-myosin heavy chain promoter. The use of engineered …

Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines …

CA Mackintosh, DJ Feith, LM Shantz, AE Pegg - Biochemical Journal, 2000 - pure.psu.edu
Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the
heart, driven from the cardiac α-myosin heavy chain promoter. The use of engineered …

Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines …

CA Mackintosh, DJ Feith, LM Shantz… - The Biochemical …, 2000 - pubmed.ncbi.nlm.nih.gov
Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the
heart, driven from the cardiac alpha-myosin heavy chain promoter. The use of engineered …